$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
多泽润达可替尼进入医保了吗?
2025-10-19 11:44:20
Check Details
非小细胞肺癌治疗新药-多泽润
2025-10-19 11:44:20
Check Details
多泽润达可替尼片效果怎样?
2025-10-19 11:44:20
Check Details
多泽润达可替尼片的耐药时间
2025-10-19 11:44:20
Check Details
多泽润医保给予报销吗?
2025-10-19 11:44:20
Check Details
多泽润治疗肺癌的效果
2025-10-19 11:44:20
Check Details
肺癌治疗用药多泽润治疗效果怎么样?
2025-10-19 11:44:20
Check Details
多泽润达可替尼片说明书
2025-10-19 11:44:20
Check Details
多泽润达可替尼片疗效怎么样?
2025-10-19 11:44:20
Check Details
Amivantamab治疗转移性EGFR外显子20插入突变非小细胞肺癌的BLA已提交FDA
2025-10-19 11:44:20
Check Details
吉泰瑞(阿法替尼)价格
2025-10-19 11:44:20
Check Details
吉泰瑞(阿法替尼)说明书
2025-10-19 11:44:20
Check Details
1
2
...
3702
3703
3704
3705
3706
3707
3708
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
3
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
4
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
5
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
6
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
7
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
8
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
9
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
10
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
11
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
12
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes